A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility (original) (raw)

Nature Genetics volume 42, pages 515–519 (2010)Cite this article

Subjects

Abstract

Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here, through a genome-wide association study of rheumatoid arthritis, we identified a polymorphism in CCR6, the gene encoding chemokine (C-C motif) receptor 6 (a surface marker for Th17 cells) at 6q27, that was associated with rheumatoid arthritis susceptibility and was validated in two independent replication cohorts from Japan (rs3093024, a total of 7,069 individuals with rheumatoid arthritis (cases) and 20,727 controls, overall odds ratio = 1.19, P = 7.7 × 10−19). We identified a triallelic dinucleotide polymorphism of CCR6 (CCR6DNP) in strong linkage disequilibrium with rs3093024 that showed effects on gene transcription. The CCR6DNP genotype was correlated with the expression level of CCR6 and was associated with the presence of interleukin-17 (IL-17) in the sera of subjects with rheumatoid arthritis. Moreover, CCR6DNP was associated with susceptibility to Graves' and Crohn's diseases. These results suggest that CCR6 is critically involved in IL-17–driven autoimmunity in human diseases.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

NCBI Reference Sequence

References

  1. Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature 423, 356–361 (2003).
    Google Scholar
  2. Newton, J.L., Harney, S.M., Wordsworth, B.P. & Brown, M.A. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 5, 151–157 (2004).
    Google Scholar
  3. Qin, S. et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746–754 (1998).
    Google Scholar
  4. Yamada, H. et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 67, 1299–1304 (2008).
    Google Scholar
  5. Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
    Google Scholar
  6. Murphy, C.A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951–1957 (2003).
    Google Scholar
  7. Pernis, A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J. Intern. Med. 265, 644–652 (2009).
    Google Scholar
  8. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803–2812 (2007).
    Google Scholar
  9. Plenge, R.M. et al. TRAF1–C5 as a risk locus for rheumatoid arthritis—a genomewide study. N. Engl. J. Med. 357, 1199–1209 (2007).
    Google Scholar
  10. Plenge, R.M. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39, 1477–1482 (2007).
    Google Scholar
  11. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
  12. Gregersen, P.K. et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 41, 820–823 (2009).
    Google Scholar
  13. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
    Google Scholar
  14. Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP genotypes from 7,003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83, 445–456 (2008).
    Google Scholar
  15. Devlin, B., Roeder, K. & Wasserman, L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 60, 155–166 (2001).
    Google Scholar
  16. Remmers, E.F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977–986 (2007).
    Google Scholar
  17. Kobayashi, S. et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum. 58, 1940–1946 (2008).
    Google Scholar
  18. Lee, H.S. et al. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol. Med. 13, 455–460 (2007).
    Google Scholar
  19. Suzuki, A. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395–402 (2003).
    Google Scholar
  20. Stahl, E.A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. advance online publication, doi:10.1038/ng.582 (9 May 2010).
  21. Annunziato, F. et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849–1861 (2007).
    Google Scholar
  22. Haas, J.D. et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing γδ effector T cells. Eur. J. Immunol. 39, 3488–3497 (2009).
    Google Scholar
  23. Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409–426 (2003).
    Google Scholar
  24. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
    Google Scholar
  25. Matsui, T. et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 α in rheumatoid arthritis. Clin. Exp. Immunol. 125, 155–161 (2001).
    Google Scholar
  26. Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn′s disease. Nat. Genet. 40, 955–962 (2008).
    Google Scholar
  27. Brand, S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58, 1152–1167 (2009).
    Google Scholar
  28. Wang, K. et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 84, 399–405 (2009).
    Google Scholar
  29. Nakamura, Y. The BioBank Japan Project. Clin. Adv. Hematol. Oncol. 5, 696–697 (2007).
    Google Scholar
  30. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
    Google Scholar
  31. Wigginton, J.E., Cutler, D.J. & Abecasis, G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76, 887–893 (2005).
    Google Scholar
  32. Kochi, Y. et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37, 478–485 (2005).
    Google Scholar
  33. Tokuhiro, S. et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35, 341–348 (2003).
    Google Scholar
  34. Suzuki, A. et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat. Genet. 40, 1224–1229 (2008).
    Google Scholar
  35. Raychaudhuri, S. et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40, 1216–1223 (2008).
    Google Scholar
  36. Thomson, W. et al. Rheumatoid arthritis association at 6q23. Nat. Genet. 39, 1431–1433 (2007).
    Google Scholar
  37. Shimane, K. et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 62, 574–579 (2010).
    Google Scholar
  38. Raychaudhuri, S. et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41, 1313–1318 (2009).
    Google Scholar
  39. Okada, Y. et al. SLC22A4 polymorphism and rheumatoid arthritis susceptibility: a replication study in a Japanese population and a meta-analysis. J. Rheumatol. 35, 1723–1728 (2008).
    Google Scholar
  40. Nishimoto, K. et al. Association study of TRAF1–C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann. Rheum. Dis. 69, 368–373 (2010).
    Google Scholar
  41. Aikawa, Y., Yamamoto, M., Yamamoto, T., Morimoto, K. & Tanaka, K. An anti-rheumatic agent T-614 inhibits NF-κB activation in LPS- and TNF-α-stimulated THP-1 cells without interfering with IκBα degradation. Inflamm. Res. 51, 188–194 (2002).
    Google Scholar
  42. Shimane, K. et al. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population. Ann. Rheum. Dis. 68, 377–383 (2009).
    Google Scholar

Download references

Acknowledgements

We thank K. Shimada, Y. Hayashi, K. Kobayashi, M. Kitazato and other members of the Laboratory for Autoimmune Diseases, RIKEN and Y. Katagiri at Tokyo Women's Medical University, for their technical assistance. We also thank the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The replication study of rheumatoid arthritis was performed under the support of Genetics and Allied research in Rheumatoid Arthritis Networking (GARNET) consortium.

Author information

Author notes

  1. Yuta Kochi and Yukinori Okada: These authors contributed equally to this work.

Authors and Affiliations

  1. Laboratory for Autoimmune Diseases, Center for Genomic Medicine (CGM), RIKEN, Yokohama, Japan
    Yuta Kochi, Akari Suzuki, Keiko Myouzen, Ryo Yamada & Kazuhiko Yamamoto
  2. Laboratory for Statistical Analysis, CGM, RIKEN, Yokohama, Japan
    Yukinori Okada, Atsushi Takahashi & Naoyuki Kamatani
  3. Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Yukinori Okada & Kazuhiko Yamamoto
  4. Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
    Katsunori Ikari, Takuji Iwamoto, Shigeki Momohara & Hisashi Yamanaka
  5. Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Chikashi Terao, Koichiro Ohmura & Tsuneyo Mimori
  6. Laboratory for Genotyping Development, CGM, RIKEN, Yokohama, Japan
    Keiko Yamazaki, Naoya Hosono & Michiaki Kubo
  7. Laboratory for Medical Informatics, CGM, RIKEN, Yokohama, Japan
    Tatsuhiko Tsunoda
  8. Laboratory for Bone and Joint Diseases, CGM, RIKEN, Yokohama, Japan
    Tatsuya Furuichi & Shiro Ikegawa
  9. Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Fumihiko Matsuda & Ryo Yamada
  10. Laboratory for International Alliance, CGM, RIKEN, Yokohama, Japan
    Yusuke Nakamura
  11. Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    Yusuke Nakamura

Authors

  1. Yuta Kochi
  2. Yukinori Okada
  3. Akari Suzuki
  4. Katsunori Ikari
  5. Chikashi Terao
  6. Atsushi Takahashi
  7. Keiko Yamazaki
  8. Naoya Hosono
  9. Keiko Myouzen
  10. Tatsuhiko Tsunoda
  11. Naoyuki Kamatani
  12. Tatsuya Furuichi
  13. Shiro Ikegawa
  14. Koichiro Ohmura
  15. Tsuneyo Mimori
  16. Fumihiko Matsuda
  17. Takuji Iwamoto
  18. Shigeki Momohara
  19. Hisashi Yamanaka
  20. Ryo Yamada
  21. Michiaki Kubo
  22. Yusuke Nakamura
  23. Kazuhiko Yamamoto

Contributions

Y.K., Y.O. and K. Yamamoto. designed the study and drafted the manuscript. Y.O., A.T., T.T. and R.Y. analyzed the GWAS data. N.H. and M.K. performed the genotyping for the GWAS. Y.K. performed expression analysis of CCR6 and functional analysis of CCR6 polymorphisms. Y.K. and K.M. established the genotyping method for CCR6DNP. K.I., S.M. and H.Y. analyzed data for the first replication cohort of rheumatoid arthritis. C.T., K.O., T.M., R.Y. and F.M. analyzed the data for the second replication cohort of rheumatoid arthritis. Y.K. analyzed the data for the Graves' disease cohort. K. Yamazaki analyzed the data for the Crohn's disease cohort. T.F. and S.I. analyzed the data for the fourth control cohort. T.I. and K.I. analyzed CCR6 expression in the synovial tissues. Y.K. and A.S. analyzed the sera of subjects with rheumatoid arthritis. M.K., N.K. and Y.N. contributed to overall GWAS study design.

Corresponding author

Correspondence toYuta Kochi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Kochi, Y., Okada, Y., Suzuki, A. et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.Nat Genet 42, 515–519 (2010). https://doi.org/10.1038/ng.583

Download citation

This article is cited by